期刊文献+

组织因子在子宫颈病变过程中的表达及其与瘤内血管生成的关系 被引量:3

Expression of tissue factor in cervical carcinogenesis and its relation to intratumoral angiogenesis
下载PDF
导出
摘要 目的通过检测子宫颈上皮内瘤变和子宫颈鳞状细胞癌组织中组织因子表达和微血管分布,探讨组织因子在子宫颈病变过程中表达水平的变化及与瘤内血管生成的关系。方法采用组织芯片技术和免疫组织化学方法,分别检测子宫颈上皮内瘤变和子宫颈鳞状细胞癌组织中组织因子的表达和微血管分布。结果组织因子在正常子宫颈组织中均不表达,而在子宫颈病变过程中其表达水平显著上调(P<0.0001),瘤内微血管密度亦显著增加(P<0.0001);同时,子宫颈病变过程中组织因子的表达水平和瘤内微血管密度呈显著正相关(r=0.3705,P<0.0001),和患者年龄无关(P=0.7089)。结论组织因子参与子宫颈癌的发生与发展,并促进瘤内微血管形成,可作为一个潜在的子宫颈癌诊断和治疗的分子靶标并应用于临床。 Objective To investigation the expression of tissue factor in cervical carcinogenesis and its relation to intratumoral angiogenesis. Methods Tissue microarray and immunohistochemistry were performed to examine the expression of tissue factor and intratumoral microvessels density in intraepithelial neoplasias (CINs) and cervical cancers. Results Immunohistochemistry results demonstrated that tissue factor was undetected in normal cervical tissues,while it was significantly up-regulated in the process of cervical carcinogenesis (P〈0.0001),and intratumoral microvessels density was increased simultaneously (P〈0. 0001). Tissue factor expression in cervical carcinogenesis was significantly correlated with intratumoral microvessels density (r=0. 1373,P〈0. 0001),but not with patient's age (P=0. 7089). Conclusion Tissue factor expression increases in cervical carcinogenesis,which might be used as a potential molecular target for diagnosis and treatment of cervical cancers.
出处 《实用肿瘤杂志》 CAS 北大核心 2009年第4期349-352,共4页 Journal of Practical Oncology
关键词 宫颈肿瘤/病理学 凝血致活酶 宫颈肿瘤/血液供给 鳞状细胞/血液供给 免疫组织化学 新生血管化 病理性 芯片分析技术 cervix neoplasms/pathology thromboplastin cervix neoplasms/blood supply carcinoma,squamous cell/ blood supply immunohistochemistry neovascularization,pathologic mierochip analytical procedures
  • 相关文献

参考文献11

  • 1谢幸.子宫颈癌的手术治疗[J].实用肿瘤杂志,2003,18(3):175-177. 被引量:11
  • 2Spicer EK,Horton R,Bloem L,et al.Isolation of cDNA clones coding for human tissue factor:primary structure of the protein and cDNA[J].Proc Nat Acad Sci USA,1987,84(15):5148-5152.
  • 3Detre S,Saclani Jotti G,and Dowsett M.A "quickscore" method for immunohistochemical semiquantitation:validation for oestrogen receptor in breast carcinomas[J].J Clin Pathol,1995,48(9):876-878.
  • 4Nitori N,Ino Y,Nakanishi Y,et al.Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma[J].Clin Cancer Res,2005,11(7):2531-2539.
  • 5Patry G,Hovington H,Larue H,et al.Tissue factor expression correlates with disease-specific survival in patients with node-negative muscle-invasive bladder cancer[J].Int J Cancer,2008,122(7):1592-1597.
  • 6Khorana AA,Ahrendt SA,Ryan CK,et al.Tissue factor expression,angiogenesis,and thrombosis in pancreatic cancer[J].Clin Cancer Res,2007,13(10):2870-2875.
  • 7Poon RT,Lau CP,Ho JW,et al.Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma[J].Clin Cancer Res,2003,9(14):5339-5345.
  • 8陈陆俊,罗光华,谈炎,魏江,吴晁,徐宁.组织因子在食管鳞癌中的表达及其临床意义[J].中华消化杂志,2008,28(9):639-641. 被引量:3
  • 9Bromberg ME,Sundaram R,Homer RJ,et al.Role of tissue factor in metastasis:functions of the cytoplasmic and extracellular domains of the molecule[J].Thromb Res,1999,82(1):88-92.
  • 10Rong Y,Post DE,Pieper RO,et al.PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma[J].Cancer Res,2005,65(4):1406-1413.

二级参考文献7

  • 1Spicer EK, Horton R, Bloem L, et al. Isolation of cDNA clones coding for human tissue factor: primary Structure of the protein and cDNA. Pro Natl Acad Sci USA, 1987, 84:5148-5152.
  • 2Khorana AA, Ahrendt SA, Ryan CK, et al. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Clin Cancer Res,2007, 13 : 2870-2875.
  • 3Seto S, Onodera H, Kaido T, et al. Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis and impact on prognosis. Cancer, 2000, 88:295-301.
  • 4Ueno T, Toi M, Koike M, et al. Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration. Br J Cancer,2000, 83: 164-170.
  • 5Nitori N, Ino Y, Nakanishi Y, et al. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma. Clin Cancer Res,2005, 11: 2531-2539.
  • 6Akashi T, Furuya Y, Ohta S, et al. Tissue factor expression and prognosis in patients with metastatic prostate cancer. Urology,2003, 62: 1078-1082.
  • 7Patry G, Hovington H, Larue H, et al. Tissue factor expression eurrelates with disease-specific survival in patients with node negative musele-invasive bladder cancer. Int J Cancer,2008, 122: 1592-1597.

共引文献12

同被引文献28

  • 1姚婵,来茂德.上皮间质转化(EMT)及其分子机制[J].国际遗传学杂志,2006,29(4):290-294. 被引量:25
  • 2Kerkela E, Ala-Aho R, Jeskanen L, et al. Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer [J]. J Invest Dermatol, 2000, 114 (6) :1113 - 1119.
  • 3Morrison C J, Buffer GS, Bigg HF, et al. Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-indepcndcnt pathway [ J ]. J Biol Chem, 2001, 276(50) :47402 -47410.
  • 4Detre S, Saclani Jotti G, Dowsett M. A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas [J]. J Clin Pathol, 1995, 48(9) :876 -878.
  • 5Hammes LS, Tekmal RR, Naud P, et al. Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease [ J ]. Gynecol Oncol, 2008, 110 ( 3 ) : 445 - 451.
  • 6Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis [J]. Annu Rev Cell Biol, 1993, 9:541 -573.
  • 7Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases : structure, function, and biochemistry [J]. Circ Res, 2003, 92(8):827-839.
  • 8Ueno H, Nakamura H, Inoue M, et al. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas [J]. Cancer Res, 1997, 57(10) :2055 -2060.
  • 9Davidson B, Goldberg I, Bemer A, et al. Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions [J]. Am J Clin Pathol, 2001, 115 (4):517 - 524.
  • 10Asano T, Tada M, Cheng S, et al. Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma [J]. J Surg Res, 2008, 146( 1): 32 - 42.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部